Ethical Psychopharmacology is a look at several different aspects of how psychoactive drugs are evaluated, marketed, and promoted by prescribers by looking at issues of transparency, research data, conflict of interest, funding sources and their interests, and informed consent. I will describe the drug approval process through the FDA, history of the DSM and how the diagnostic process has been influenced by money, big Pharma, and conflict of interest. We will look at some clever marketing messages and the difference between marketing and science. 

Register Now

Live Webinar

May 17th, 2024

Objectives

• Describe process of drug development at the FDA.
• Discuss how the DSM diagnoses have increased and how it influences prescribing.
• Identify common marketing myths ‘in the wild’.
• Provide compassion for those on psychoactive drugs, empower informed consent, to question their effectiveness, and to understand the risk/benefit of their use.
• Identify ways in which money and influence have altered the scientific process.
• Use learned vocabulary to ask questions, do background research, and gain confidence in their ability to understand the area.

Audience

This workshop will be beneficial to behavioral health and human service practitioners, including psychologists, social workers, counselors, marriage and family therapists, substance use and addictions professionals, clinicians and all others interested in this topic.